Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244
26 - 50 out of 57Page size: 25
Sort by: Start date
  1. 2015

  2. Nature Genetics (Journal)

    Andersen, Jesper Bøje (Review editor)

    2015

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  3. 2014

  4. ILCA: Decoding Tumor Heterogeneity Informs Targeted Therapies in Intrahepatic Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    4 Sep 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  5. Molecular Classification of Cholangiocarcinoma and Therapeutic Implications

    Andersen, Jesper Bøje (Invited speaker)

    9 May 2014

    Activity: Talk or presentation types › Lecture and oral contribution

  6. Eu-Life: Translational Working Group (External organisation)

    Andersen, Jesper Bøje (Member)

    2014

    Activity: Membership types › Membership in committee, council, board

  7. The Cancer Genome Atlas (TCGA), Cholangiocarcinoma Analysis Working Group (External organisation)

    Andersen, Jesper Bøje (Member)

    2014 → …

    Activity: Membership types › Membership in research network

  8. 2013

  9. Emerging Targets in the treatment of Cholangiocarcinoma: Liver cancer seminar

    Andersen, Jesper Bøje (Lecturer)

    20 Nov 2013

    Activity: Talk or presentation types › Lecture and oral contribution

  10. AASLD: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma.: Experimental Hepatocarcinogenesis

    Andersen, Jesper Bøje (Speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  11. Bench to Bedside: New Directions for Therapy in Primary Liver Cancer: Cancer Biology Symposium

    Andersen, Jesper Bøje (Invited speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  12. Bench to Bedside: Translational genomics identifies promising targeted therapy for cholangiocarcinoma: Humanitas Fondazione per la Ricerca Seminars

    Andersen, Jesper Bøje (Lecturer)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  13. Georgetown University, Lombardi Comprehensive Cancer Center: Emerging Genomics-based Targets in the treatment of Cholangiocarcinoma: Ruesch symposium on HCC

    Andersen, Jesper Bøje (Invited speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  14. Gut, Molecular Carcinogenesis, Oncogene (Journal)

    Andersen, Jesper Bøje (Review editor)

    2013

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  15. ILCA: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2013

    Activity: Talk or presentation types › Lecture and oral contribution

  16. The Italian chapter of the International Cholangiocarcinoma Network (External organisation)

    Andersen, Jesper Bøje (Member)

    2013

    Activity: Membership types › Membership in research network

  17. 2012

  18. British Journal of Cancer; Journal of Cancer Therapeutics & Research, BMC Cancer; Cancer Research; Clinical Cancer Research; PLoS ONE (Journal)

    Andersen, Jesper Bøje (Review editor)

    2012

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  19. ILCA workshop: Signalling pathways and molecular therapies in liver cancer: Rationale for Targeted Therapies in Intrahepatic Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  20. ILCA: Application of Translational Genomics for Targeted Therapy in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  21. Novel Therapeutic Approaches for Treatment of Primary Liver Cancer: Epigenomic-driven therapy

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  22. The Hepatobiliary Cancers Foundation (CanLiv): Genomic Basis for Targeted Therapies in Cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2012

    Activity: Talk or presentation types › Lecture and oral contribution

  23. 2011

  24. Gastroenterology; Liver Transplantation; Clinical Gastroenterology & Hepatology (Journal)

    Andersen, Jesper Bøje (Review editor)

    2011

    Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

  25. Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

    Andersen, Jesper Bøje (Speaker)

    2011

    Activity: Talk or presentation types › Lecture and oral contribution

  26. ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

    Andersen, Jesper Bøje (Speaker)

    2011

    Activity: Talk or presentation types › Lecture and oral contribution

  27. 2010

  28. ILCA: Transcriptomic classification and survival prediction of human cholangiocarcinoma

    Andersen, Jesper Bøje (Speaker)

    2010

    Activity: Talk or presentation types › Lecture and oral contribution

  29. International Liver Cancer Association (ILCA) (External organisation)

    Andersen, Jesper Bøje (Member)

    2010

    Activity: Membership types › Membership in research network

  30. 2009

  31. Aging (Journal)

    Andersen, Jesper Bøje (Editor)

    2009 → 2013

    Activity: Peer-review and editorial work types › Editor of Research journal › Research

  32. American Association for Cancer Research (AACR) (External organisation)

    Andersen, Jesper Bøje (Member)

    2009

    Activity: Membership types › Membership in research network

Previous 1 2 3 Next

ID: 93714085